https://www.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Advances-Oncology-Portfolio-with-New-Data-from-Phase-3-ASCENT-Trial-of-Trodelvy-in-31994016/?utm_source=telegram&utm_medium=social&utm_campaign=share